Defensive allocation away from the AI trade
The long-term growth strategy presented by Oxbow Advisors focuses on allocating capital to reasonably priced, high-quality industrials, healthcare, and financials rather than chasing overvalued AI and semiconductor stocks.
The argument
The guest argued that they are playing defense in the current market environment because they believe the market is close to the end of its cycle. They are focusing on steady, niche industrial businesses, drug distributors benefiting from GLP-1 trends, and high-quality super regional banks.
The thesis, stress-tested
✓ What validates it
- ✓Outperformance of defensive sectors relative to technology during a market correction
- ✓Stable earnings growth from the named holdings despite broader macroeconomic slowing
▸ Risks discussed
- ▸Missing out on continued short-term momentum in the AI and semiconductor sectors
Hear it yourself
"McKesson is one of the three big drug distributors. The emphasis on GLP one weight loss drugs, they've been a beneficiary of that because they're one of the companies distributing it, around the country. So in addition to health care and then US Bancorp is probably the biggest, highest quality of the super regional banks. So when you look at that broadly, industrials, health care, financials, those"
50:28 · 50:28
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE